# Movetis NV

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/movetis

- Industry: Pharmaceuticals
- Headquarters: Belgium
- Website: www.movetis.com
- Total disclosed funding: $65M
- Latest round: Series A (Jan 8, 2007)
- Investors on record: 6

## About

Movetis NV is a Belgian company focused on domain name transactions, offering services in buying, leasing, and transferring premium domain names to both individuals and businesses.Movetis NV, founded in 2006, specializes in domain name transactions and has undergone significant changes since its inception. The company went public through an IPO on December 4, 2009, raising EUR 85 million. Movetis was later acquired by Shire PLC in August 2010. The company operates out of Belgium.Movetis NV specializes in the buying and leasing of domain names, facilitating secure transactions for clients seeking to establish an online presence. One of its primary offerings is the sale of premium domain names, including movetis.com, priced at EUR 4,995. Customers can also opt for a Lease to Own program at EUR 714 per month, catering to those preferring a manageable financial commitment. Its clientele spans individuals and businesses across multiple industries, with a focus on providing reliable domain solutions.For the most recent fiscal year in 2011, Movetis reported a revenue of EUR 2,644,805.60, with an EBITDA of EUR 660,148.30. The company's revenue primarily comes from direct sales and leasing of domain names, structured as one-time payments or subscription models, thereby appealing to a diverse customer base.Movetis NV aims to leverage its IPO funding to expand its service offerings and enter new markets. The company is strategizing to introduce new premium domain names and enhance its leasing options. Specific geographic markets targeted for expansion include the European and North American regions by 2012. The funding raised will support these initiatives, facilitating increased marketing efforts and operational capabilities in the targeted regions.

## Funding rounds

- Series A, Jan 8, 2007, $65M — Sofinnova Partners, EQT Life Sciences, Gimv, BIP Investment Partners, KBC Private Equity, Quest Management

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A
- Gimv (https://capitalatlas.ai/funds/gimv) — Series A
- BIP Investment Partners (https://capitalatlas.ai/funds/bip-investment-partners) — Series A
- KBC Private Equity (https://capitalatlas.ai/funds/kbc-private-equity) — Series A
- Quest Management (https://capitalatlas.ai/funds/quest-management) — Series A